Biotechnology Startups in New Jersey

Claris Biotherapeutics, Inc. is a pioneering biotechnology company dedicated to the development of innovative therapies specifically aimed at treating corneal diseases. With a particular focus on neurotrophic keratitis (NK), a rare and debilitating condition that can lead to significant vision loss, Claris is committed to addressing critical unmet medical needs in this niche area of ocular health.

Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to transforming cancer treatment through pioneering biologically-based therapies. The company is firmly committed to addressing the pressing challenge of drug resistance in cancer treatment by developing innovative medications that work by reactivating cell death mechanisms.

Grace Therapeutics, Inc. is a late-stage biopharmaceutical company dedicated to the development of innovative drug delivery technologies aimed at improving treatments for rare and orphan diseases. With a focus on enhancing the performance of existing therapies, the company seeks to expedite the onset of action, augment efficacy, minimize side effects, and provide more user-friendly delivery options for patients.

IVIEW Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing innovative treatments for ocular diseases. By focusing on unmet medical needs in the ophthalmology sector, the company aims to create effective therapies for conditions including dry eye disease, conjunctivitis, myopia, glaucoma, and presbyopia.

Outlook Therapeutics is a pioneering biopharmaceutical company specializing in the development and commercialization of ophthalmic medications. The company is committed to addressing significant unmet medical needs in the treatment of retinal diseases through innovative therapeutic solutions.